Inactive Instrument

Insiders ATHENEXPAR

Equities

ATNX

US04685N2027

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Athenex, Inc. Announces the Separation of Joe Annoni as Assistant Chief Restructuring Officer	23-08-17	CI
Optimism Over Potential Debt Limit Increase Lifts Exchange-Traded Funds, Equity Futures Pre-Bell	23-05-15	MT
Athenex, Inc Appoints Nick Campbell as Chief Restructuring Officer	23-04-25	CI
Athenex, Inc. Appoints Darrel P. Cohen, MD, PhD as Chief Medical Officer of Cell Therapy to Lead Its Clinical Development, Clinical Operations, and Regulatory Affairs Functions	22-06-08	CI
Kim Campbell Not to Stand for Re-Election to the Athenex Board of Directors At the 2022 Annual Meeting of Stockholders	22-04-15	CI
Athenex Announces Appoints Joe Annoni as Chief Financial Officer	22-02-22	CI
Athenex, Inc. Announces Executive Changes	21-12-28	CI
BM Technologies : Names Li Shen Chief Accounting Officer	21-09-30	MT
Insider Buy: Athenex	21-09-14	MT
Athenex, Inc. Announces Resignation of Randoll Sze as CFO, Effective August 13, 2021	21-08-05	CI
Athenex, Inc. Appoints Steven Adams as Interim Chief Accounting Officer of the Company	21-08-05	CI
Biopharmaceutical Leader Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of Directors	20-08-04	GL
Athenex Announces Board Changes	20-08-04	CI
Athenex, Inc. Announces Promotion of Teresa Bair, Esq. to Executive Officer as General Counsel and Senior Vice President, Administration	20-06-23	CI
Athenex Appoints Daniel Lang as Senior Director of Corporate Development	19-09-04	CI
Athenex, Inc. Announces Appointment of John Koh as A New Board Member	19-04-02	CI
Athenex, Inc. Announces Board Changes	19-03-29	CI
Athenex, Inc. Announces Board Changes	19-03-21	CI
Athenex, Inc. Announces Preliminary Results of Patients Receiving T-Cell Receptor Affinity Enhancing Specific T-Cell Therapy; Announces Management Changes	18-10-15	CI
Athenex, Inc Appoints Randoll Sze as Chief Financial Officer	18-08-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders ATHENEXPAR

Equities

ATNX

US04685N2027

Insiders

Filters